Spotting the Zebra: Understanding and Enhancing Appropriate Medical Management for Patients with Eosinophilic Granulomatosis with Polyangiitis (EGPA) and Hypereosinophilic Syndrome (HES)
Eosinophilic granulomatosis with polyangiitis (EGPA) and hypereosinophilic syndrome (HES) are two distinct and rare eosinophilic disorders that can be associated with significant morbidity to include an increased risk of permanent organ damage if not properly diagnosed and managed. This educational program will assist population-based decision makers with enhancing their understanding of these rare conditions and support appropriate medical management for patients with these disorders.
This program will review:
- Disease state pathophysiology of both EGPA and HES
- The burden and unmet medical needs for patients with these disorders
- Guideline recommendations for the management of these conditions
At the end of the program, attendees should be able to
- Understand the pathophysiology and organ systems affected by EGPA and HES
- Recognize the burden and unmet medical needs for patients with these conditions
- Discuss the current treatment guidelines for management of patients with these disorders
Speakers:
- Tom Corbridge, MD, FCCP
Emeritus Physician, Northwestern Memorial Hospital
Adjunct Professor of Medicine, Division of Pulmonary and Critical Care Medicine, Northwestern University Feinberg School of Medicine Senior Director, Medical Respiratory, GSK
US Medical Affairs
Respiratory Therapeutic Area
GlaxoSmithKline, US Medical Affairs
This webinar is sponsored, developed and presented by the sponsor. The content of this Science & Innovation Webinar and opinions expressed by the presenters are those of the sponsor or presenters and not of AMCP.
Sponsored by:
For individuals from the media/press who are interested in attending, please email media@amcp.org.
